已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Cost‐effectiveness analysis of four glucagon‐like peptide‐1 or glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonists for the treatment of adult patients with overweight and obesity in China

利拉鲁肽 医学 赛马鲁肽 超重 内科学 成本效益分析 人口 肥胖 成本效益 糖尿病 内分泌学 2型糖尿病 环境卫生 风险分析(工程)
作者
Wu Fu,Jingwen Lin,Caicong You,Jiahao Zhang,Jianying Lei,Liushi Zheng,Bin Zheng,Maobai Liu,Libin Liu,Na Li
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:27 (9): 5280-5290 被引量:8
标识
DOI:10.1111/dom.16581
摘要

AIMS: To evaluate the cost-effectiveness of liraglutide, semaglutide, tirzepatide, benaglutide, and lifestyle management for the treatment of obesity from the perspective of the Chinese healthcare system. MATERIALS AND METHODS: This study gathered clinical trial data from literature reviews of each treatment strategy for patients with obesity without diabetes, and efficacy data were synthesized using network meta-analysis. The data were subsequently incorporated into an constructed Markov model to simulate the lifetime treatment trajectory of patients, with a cycle length of one year. The model integrated epidemiological data from China, clinical efficacy, treatment costs, and utilities, calculating the total treatment costs and quality-adjusted life years, followed by incremental cost-effectiveness analysis. The willingness-to-pay (WTP) threshold was set at three times the per capita gross domestic product (GDP), amounting to $37 067.75. Sensitivity analysis and scenario analysis were performed. RESULTS: The incremental cost-effectiveness ratios compared to lifestyle management for benaglutide, liraglutide, semaglutide, tirzepatide (10 mg), and tirzepatide (15 mg) were $227 355.26, $47 994.81, $42 818.20, $72 380.49, and $89 147.19. The base-case results indicated that, under the WTP threshold, none of the four glucagon-like peptide-1 receptor agonist (GLP-1RA) or glucose-dependent insulinotropic polypeptide (GIP)/GLP-1RA therapies were cost-effective compared with lifestyle management. In the probabilistic sensitivity analysis, under the WTP threshold, lifestyle management was the most likely to be cost-effective. Scenario analysis showed that, in the severe obesity patient population and in first-tier cities in China, semaglutide is the most cost-effective treatment option. CONCLUSIONS: GLP-1 RA or GIP/GLP-1RA are not cost-effective for obesity treatment in China currently. Nevertheless, semaglutide exhibits relatively favourable economic potential across multiple subgroups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
街道办柏阿姨完成签到 ,获得积分10
刚刚
wise111发布了新的文献求助10
2秒前
2秒前
沉静曼梅完成签到,获得积分10
5秒前
小丸子发布了新的文献求助10
5秒前
OMIT发布了新的文献求助10
5秒前
fantasy的应助被科研通管家采纳,获得10
6秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
6秒前
香蕉觅云的应助被科研通管家采纳,获得10
6秒前
Jasper的应助被科研通管家采纳,获得10
6秒前
6秒前
SavvyYung完成签到,获得积分10
6秒前
爆米花的应助被科研通管家采纳,获得10
6秒前
江氏巨颏虎完成签到,获得积分10
6秒前
深情安青的应助被科研通管家采纳,获得10
6秒前
孙睿完成签到 ,获得积分10
7秒前
慕鳞完成签到,获得积分10
8秒前
Isaac完成签到,获得积分10
10秒前
11秒前
慕鳞发布了新的文献求助10
12秒前
爱you完成签到,获得积分10
12秒前
啊啊啊啊完成签到,获得积分10
12秒前
15秒前
毛绒绒窝铺完成签到,获得积分10
16秒前
焦糖布丁的滋味完成签到,获得积分10
19秒前
亭曈完成签到 ,获得积分10
19秒前
20秒前
舟舟发布了新的文献求助10
20秒前
22秒前
大力的含卉完成签到 ,获得积分10
23秒前
中华大团团完成签到,获得积分10
23秒前
ABCD完成签到 ,获得积分10
23秒前
刘旺发布了新的文献求助30
29秒前
bkagyin的应助被爱you采纳,获得10
29秒前
35秒前
乐乐的应助被小叶不吃香菜采纳,获得10
35秒前
Han完成签到 ,获得积分10
35秒前
赵悦完成签到 ,获得积分10
37秒前
mashibeo发布了新的文献求助10
38秒前
淡定的代丝完成签到 ,获得积分10
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179640
求助须知:如何正确求助?哪些是违规求助? 9569910
关于积分的说明 21807611
捐赠科研通 7775123
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557032
邀请新用户注册赠送积分活动 2478768